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Istituto di Chimica del Riconoscimento Molecolare, Consiglio Nazionale Delle Ricerche, Milan, ItalyABSTRACT An increasing number of functional studies of proteins have shown that sequence and structural similarities alone
may not be sufﬁcient for reliable prediction of their interaction properties. This is particularly true for proteins recognizing speciﬁc
antibodies, where the prediction of antibody-binding sites, called epitopes, has proven challenging. The antibody-binding prop-
erties of an antigen depend on its structure and related dynamics. Aiming to predict the antibody-binding regions of a protein, we
investigate a new approach based on the integrated analysis of the dynamical and energetic properties of antigens, to identify
nonoptimized, low-intensity energetic interaction networks in the protein structure isolated in solution. The method is based on
the idea that recognition sites may correspond to localized regions with low-intensity energetic couplings with the rest of the
protein, which allows them to undergo conformational changes, to be recognized by a binding partner, and to tolerate mutations
with minimal energetic expense. Upon analyzing the results on isolated proteins and benchmarking against antibody complexes,
it is found that the method successfully identiﬁes binding sites located on the protein surface that are accessible to putative
binding partners. The combination of dynamics and energetics can thus discriminate between epitopes and other substructures
based only on physical properties. We discuss implications for vaccine design.INTRODUCTIONUnderstanding protein-protein interactions is a crucial step in
the development of a molecular view of biological processes
and in learning how to manipulate them. The progress of
genomics and proteomics provided a great deal of information
on the sequences, thermodynamics, kinetics, biological func-
tions, and structures of an ever-growing number of protein
complexes. However, these techniques can be expensive
and time-consuming. Consequently, computational methods
have gained increasing importance in the field: the ability to
predict interaction interfaces is in fact a fundamental prereq-
uisite to understand complex formation, particularly for novel
folds with little or no similarity with known molecules.
Protein interaction sites have been analyzed in terms
of sequences, physico-chemical profiles, B-factors, solvent
accessibility, structures, homologies, and similarities, etc.
(1–10). These properties have been combined in different
ways in algorithms for the prediction of protein interfaces
in biomolecular complexes (for a review on methods and
their performances, see (1)).
A particular role in protein-protein interactions is played
by antigen-antibody recognition. The limited number of
available protein-antibody structures has somehow hampered
the development of methods for the prediction of antibody
binding sites, known as epitopes (11,12). However, the
renewed interest in vaccine development gave new impulse
to this field. Vaccination represents one of the most reliable
strategies to fight infections and overcome the onset of drug-
resistance by an ever-growing number of pathogens (13–17).Submitted October 14, 2009, and accepted for publication January 11, 2010.
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0006-3495/10/05/1966/10 $2.00One of the main challenges in the discovery of new vaccines
is the discrimination of the components capable of eliciting
a protective immune response from the thousands of differ-
ent (macro)molecules of the pathogen. In this context, the
reverse vaccinology approach (RV) (18–22) has introduced
a new paradigm of candidate selection and vaccine develop-
ment. RV involves the analysis ofmultiple genomes of related
pathogens, followed by in silico identification and experi-
mental expression of potential surface-exposed proteins.
Vaccine candidates are then produced and tested for their
capacity to induce protective immunity (20,23). This strategy
led to the identification of protective vaccines against Neisse-
ria meningitidis or Group B Streptococcus.
Complementing RV strategies with structural informa-
tion on the antigens may open up a new era of vaccinology
based on the possibility of rationally designing new protein-
vaccines with optimized properties. High-resolution struc-
tural information on relevant antigens in complex with their
respective antibodies or in isolation has indeed begun to
appear (24,25).
A fundamental step toward structural-vaccinology relies on
our ability to predict epitopes for a given protein and elucidate
their physico-chemical properties. The structure, dynamics,
and energetics of a specific site on a protein domain, or of
the protein domain as a whole (24), play a main role in deter-
mining the antigenic properties of specific (fragments of)
protein constructs, the interaction of epitopes with antibodies,
and their relevance for a protective response (26).
An epitope may be either a short linear stretch from the
protein sequence, defined as a continuous or linear epitope,
or a three-dimensional, organized substructure consisting
of different segments that come together in the three-dimen-
sional structure, but are distant in the primary sequence,doi: 10.1016/j.bpj.2010.01.014
MD-Based Epitope Prediction 1967known as discontinuous or conformational epitope. Most
neutralizing epitopes in antibody-mediated responses are
discontinuous. The fundamental mechanism of action of
most vaccines in clinical use is to present these complex
structures to antibodies that specifically bind them and start
neutralization processes (24,27).
Prediction of linear epitopes can now be reliably achieved
using sequence-dependent methods (12,28). In contrast, the
prediction of conformational epitopes is more challenging
and the knowledge of the three-dimensional structure of
the protein-antigen is a prerequisite. Several correlations
among flexibility, solvent accessibility, geometrical proper-
ties, approximations of protein shape together with clustering
of neighboring residues, and antigenicity, have been proposed
(12,29–33).
Most epitope prediction methods are based on the use of
single structures from x-ray crystallographic studies. Pro-
teins are, however, highly dynamical entities, and their func-
tions are intimately correlated to motions (34–38). All-atom
molecular dynamics (MD) simulations allow the investiga-
tion of these motions on a range of timescales, revealing
interactions, correlations, and conformations that may be
relevant in determining recognition processes. The utility
of MD simulations in functional elucidation, analysis, and
drug design has already been proved (29,35,39–42).
Herein, we report on the application of a novel method
for epitope prediction based on the integrated analysis ofTABLE 1 Performance of the MLCE method in epitope prediction
Antigen Antibody complexes
MD
AUC
MM
AUC Sen
1AO3 1FE8, 2ADF 0.5 0.37 0
1AUQ 1OAK 0.89 0.95 0
1BV1 1FSK 0.64 0.41 0
1CK4 1MHP 0.88 0.71 0
1CMW 1BGX 0.64 0.62 0
1D7P 1IQD 0.82 0.85 0
1GWP 1AFV 0.58 0.55 0
1HCN 1QFW 0.81 0.73 0
1K59 1H0D 0.87 0.87 0
1KDC 1NSN, 2GSI 0.67 0.66 0
1KZQ 1YNT 0.56 0.61 0
1P4P 1RJL 0.98 0.98 1
1PKO 1PKQ 0.84 0.7 0
1POH 2JEL 0.25 0.24 0
1TFH 1AHW 0.69 0.66 0
1UW3 1TPX 0.94 0.91 0
2VPF 1BJ1, 2FJG, 2FJH, 1TZH, 1CZ8 0.49 0.56 0
3LZT 1FDL, 1YQV, 1MLC, 1IC4, 1NDG,
1DQJ, 1NDM, 1P2C, 2ZNW
0.67 0.66 0
7NN9 1NCA, 1NMC 0.72 0.57 0
Mean 0.71 0.66 0
Columns 1 and 2: List of the Protein DataBank (PDB) codes of the isolated prote
their respective antibodies, which were used for benchmarking. Columns 3–9: Ar
energies (MLCE) approach on the structures obtained from extensive molecular d
on the PDB structure; sensitivity; specificity; accuracy; positive predicted value (
calculated from MD simulations.
*Calculated according to Ponomarenko and Bourne (11).the energetic and structural-dynamical properties of antigens
(43–47). Our approach aims at identifying ab initio antigen
substructures poised to interact with binding partners in
general, and antibodies in particular. The method is based
on the physico-chemical properties of the antigen protein in
isolation (Table 1, and Table S1 in Supporting Material),
without requiring any previous knowledge on antibody
binding of related homologs, or training with a data set of
known sequences, geometric descriptors, antibody-protein
interactions, etc. Reliable physics-based prediction of a
discontinuous epitope may have implication for vaccine
design, allowing the development of mutants or mimics that
favor the specific conformation required for antibody binding
or the optimization of antigen stability without affecting the
epitope site.MATERIAL AND METHODS
Theoretical justiﬁcation
Epitopes are parts of the protein that can be recognized by a binding partner.
Their sequences are typically mutation-tolerant (32), suggesting that they are
not involved in the stabilization of the antigen fold. These sites have evolved,
and must continuously evolve, to escape recognition by the host immune
system, without impairing the native structure of the protein necessary for
function in the pathogen (see (24) and references therein).Moreover, epitopes
can beflexible and easily undergo conformational fluctuations (11,29,48–50).
In otherwords, they are not involved inmajor intramolecular stabilizing inter-
actions with other residues of the protein important to preserve the fold.sitivity Specificity Accuracy PPV*
No. of
epitopes
Interface
residues
.12 0.77 0.65 0.1 2 33
.78 0.79 0.79 0.15 1 9
.35 0.78 0.74 0.16 1 17
.92 0.78 0.79 0.22 1 12
.3 0.77 0.76 0.05 1 30
.67 0.80 0.79 0.3 1 18
.3 0.90 0.72 0.58 3 47
.54 0.86 0.81 0.38 2 28
.73 0.85 0.84 0.41 1 15
.41 0.85 0.74 0.45 2 32
.36 0.74 0.70 0.12 1 22
0.89 0.9 0.48 1 13
.56 0.92 0.86 0.53 1 18
0.83 0.62 0 1 21
.3 0.82 0.75 0.21 1 27
.67 0.95 0.92 0.62 1 12
.21 0.89 0.61 0.57 2 40
.2 0.92 0.56 0.72 3 65
.36 0.79 0.76 0.11 1 25
.46 0.84 0.75 0.32 1.42 18.6
ins studied and used for prediction in this article and of the complexes with
ea under the curve (AUC) values calculated with the matrix of local coupling
ynamics (MD) simulations; from molecular mechanics (MM) minimization
PPV); number of epitopes in the protein; number of residues in the epitopes,
Biophysical Journal 98(9) 1966–1975
1968 Scarabelli et al.From the conformational and topological standpoints, epitopes are
exposed regions on the protein surface, accessible for antibody binding
(30). Moreover, specifically in the case of discontinuous epitopes, high-reso-
lution x-ray structures of antigen-antibody complexes showed they consist
of residues whose spatial proximity relationships define a (large) patch on
the surface of the antigen (25,51).
Based on these considerations, we have set out to combine an analysis of
protein energetics obtainable from MD simulations with the topological
information obtainable from the contact matrix of the representative struc-
ture of the trajectory (47). We wish to identify contiguous regions in the
three-dimensional conformation of the antigen that are minimally coupled
to the rest of the protein, and are thus likely sites for the dynamic modulation
that would play a role in recognition events.
The analysis of energetics is based on our energy decomposition method,
which allows the detection of residue-residue couplings that are important in
the stabilization of a fold (see details in the next paragraph). The method
provides a simplified view of residue-residue pair interactions, extracting
the major contributions to energetic stability of the native structure from
the results of all-atom MD simulations. For a protein of N residues, the
NN matrix (Mij) of average nonbonded interactions between pairs of resi-
dues can be built by averaging over the structures visited during an MD
trajectory (43–47). The rather noisy energy matrix is then simplified through
eigenvalue decomposition. Analysis of the N components of the eigenvector
associated with the lowest eigenvalue was shown to identify residues that
behave as strong interaction centers. These interaction centers are them-
selves characterized by components that have an intensity higher than the
threshold value, and which correspond to a flat normalized vector with resi-
dues that would all provide the same contribution. We verified that applying
this analysis to the representative conformation of the most populated struc-
tural cluster from the simulation yields the same results as the averaging over
the equilibrated part of the trajectory (52). As a caveat, it is worth noting that
the latter approximation is valid when the most frequented cluster is signif-
icantly more populated than the others, so as not to neglect significant struc-
tural deviations captured by other clusters. In all the cases studied here this
holds true, as we did not observe any major domain rearrangements, domain
motions, or folding-unfolding events during simulations. The method was
validated against experimental data and a relationship was found between
the topological and energetic properties of a protein and its stability (43–47).
The map of pair energy-couplings filtered with topological information
can be used to identify local couplings characterized by energetic interac-
tions of minimal intensities. Because low-intensity couplings between
distant residues in the structure are a trivial consequence of the distance-
dependence of energy functions, local low-energy couplings identify those
sites in which interaction-networks are not energetically optimized. These
regions may be regarded, therefore, as prone to interact with binding partners
or to otherwise tolerate mutations that would preserve the antigen three-
dimensional structure. Moreover, thanks to the lower intensity constraints
to the rest of the structure, these substructures would be characterized by
dynamic properties that allow them to visit multiple conformations (as
shown in the flexibility graphs in Supporting Material)—a subset of which
can be recognized by the antibody to form a complex. The sites identified are
typically clustered at the protein surface and are easily accessible. These
concepts are somewhat reminiscent of local frustration, in which highly
frustrated regions are often localized near interaction sites on protein
surfaces (53).
Analysis of energetics and topological properties
The energy decomposition method is based on the calculation of the interac-
tion matrix Mij, which is determined by evaluating average, interresidue,
nonbonded (van der Waals and electrostatics) interaction energies between
residue pairs, calculated over the structures visited during an MD trajectory.
For a protein of N residues, this calculation yields an NN matrix. As stated
above, the same results can be obtained by calculating the interaction matrix
Mij from the representative conformation of the most populated cluster, in
the absence of major conformational changes.Biophysical Journal 98(9) 1966–1975The aim of our method is to obtain a simplified picture of the most rele-
vant residue-residue interactions in a certain fold. The matrix Mij is thus
diagonalized and reexpressed in terms of eigenvalues and eigenvectors, in
the form
Mij ¼
XN
k¼ 1
lkw
k
i w
k
j ; (1)
where N is the number of protein amino acids, lk is the k
th eigenvalue with k
ranging from 1 to N, and wki and w
k
j are the i
th and jth components of the
associated normalized eigenvector. Eigenvalues are labeled following an
increasing order, so that l1 is the most negative. In the following, we refer
to the first eigenvector as the eigenvector corresponding to eigenvalue l1.
The total nonbonded energy Enb is defined as
Enb ¼
XN
i; j¼ 1
Mij ¼
XN
i; j¼ 1
XN
k¼ 1
lkw
k
i w
k
j : (2)
We showed in Tiana et al. (43) and Morra and Colombo (47) that each Mij
can be effectively approximated by
Mijz ~Mij ¼ l1w1i w1j ; (3)
such that the total nonbonded energy becomes
EnbzE
app
nb ¼
XN
i; j¼ 1
~Mij ¼
XN
i; j¼ 1
l1w
1
i w
1
j : (4)
(A distribution of the eigenvalues and the percentage of total stabilization
energy accounted for by l1w
1
iw
1
j can be found for each protein in Table S2.)
From the physical point of view, this approximation indicates that any two
residues i and j interact with energy l1w
1
iw
1
j. The value l1 represents
a coupling parameter: a modulation of its intensity, as a result of mutations,
can be interpreted as a rescaling in the intensity of protein interactions. A
variation in the eigenvector components is related to a reorganization of
native interactions that would modulate the contribution of a certain pair
to the overall stability.
The principal eigenvector (defined as the sequence eigenvector) consti-
tutes a simple vectorial representation of the sequence: it reports on the
contribution of each residue in the stabilization of the fold, which ultimately
depends on the chemical properties of the residue itself. From this we can
recover an approximation to the global stabilization energy, Eappnb , which
was shown to correlate with the relative different stabilities of mutants of
several proteins, proving thereby to be a sufficient energetic descriptor to
discriminate among them (47). This method provides information on the
mean coupling energy between two residues in the native state, revealing
the network of most interacting residues through the structure.
The contact map of the representative structure from MD recapitulates
which residue pairs are in contact in the conformation. If the distance
between any two Cb atoms is below a cutoff value, the corresponding matrix
entry is set to 1, otherwise it is set to 0. The distance cutoff is set to 6.5 A˚. For
the sake of homogeneity with the energy matrix, contacts between nearest
neighbors i, iþ1 are included as well. Therefore,
Cij ¼ 1 rij%6:50 rij > 6:5 :

(5)
To calculate the contact matrices we consider the representative structure of
the main cluster obtained with the GROMOS method from the MD trajec-
tory of each antigen (cutoff value of 2 A˚) (54). Energy decomposition
was carried out both by averaging on structures saved every nanosecond
during the simulations and on the representative protein conformation of
the most populated structural cluster obtained from the trajectory. The result-
ing structures were minimized, and solvation effects were taken into account
using the molecular-mechanics (MM)-Poisson-Boltzmann surface area
MD-Based Epitope Prediction 1969(PBSA) method, with the nonbonded energy term for residues i and j result-
ing (55) in
Enbij ¼ Eelect;ij þ EvdW;ij þ Gsolv;ij:
The results of averaging over the trajectory and of considering the most
populated cluster are basically identical. A schematic of the method is
reported in Fig. 1.
Epitope identiﬁcation
The simplified interaction matrix defined by l1w
1
iw
1
j is multiplied by the
residue-contact matrix. This procedure allows us to filter the information
contained in the simplified energy matrix l1w
1
iw
1
j in terms of residues
that are close in space, highlighting pairs within the contact cutoff that are
also coupled through nonbonded interactions. This provides a compact
way to highlight which local pair-contacts in the three-dimensional organi-
zation of the protein are coupled through energetic interactions.
The resulting matrix can be viewed as the matrix of local coupling
energies (MLCE). The contact-filtered coupling interactions are ranked in
increasing order according to their respective intensities (from weaker toFIGURE 1 Pictorial representation of the MLCE method. The contact
map is multiplied by the simplified energy-coupling matrix. The resulting
matrix reports the energetic coupling intensity of two residues in contact
in space, represented as a color scale assigned to each point of the matrix.
The weakest local interactions vanish in the background color: predicted
epitopes are identified with circles.stronger). Starting from the minimum value (weakest local coupling interac-
tions, defined as ‘‘soft spots’’, in contrast with the ‘‘hot spots’’ characterized
by high coupling intensities), the set of putative interaction sites was defined
by including increasing residue-residue coupling values until the number of
couplings that correspond to the lowest 15% of all contact-filtered pairs was
reached. This then corresponds, in our approximation, to the set of local
interactions, possessing minimal intensities, which may identify antigen-
antibody or protein interaction sites. The corresponding residues define puta-
tive epitope sequences.
Simulation setup
All the starting structures were downloaded from the Protein DataBank
(codes in Table 1) and each was subjected to five explicit water MD simu-
lations of 30 ns as described in the Supporting Material.RESULTS
Epitope prediction based on energy
decomposition
To evaluate the ability of our method to predict epitopes, we
studied 19 protein antigens for which crystal structures were
available both in isolation and in complex with at least one
specific antibody in the Protein DataBank (PDB). The data-
set was constructed by searching the PDB and initially
discarding all complexes involving antibodies bound with
only short peptide stretches, and focusing only on real
protein-protein complexes. Moreover, we selected antigen
proteins whose structures had been solved in isolation via
x-ray crystallography with a resolution<2.6 A˚ or via nuclear
magnetic resonance (Table S1). The set of isolated antigens
was chosen to be nonredundant and diverse in terms of
structures and sequences (alignments shown in Supporting
Material). Structural similarities were also minimal, because
the antigens and epitopes were comprised from a diverse
group of possible conformations that ranged from random
loops to ordered secondary structures (Fig. 2).
The predictive analysis was performed based only on MD
simulations starting from the x-ray structure of the antigenic
proteins in isolation. The validity of the epitope prediction
was benchmarked against the corresponding structure of the
antibody-complexed antigen (see Table 1). Our method
does not require the use of any training set of antibody-antigen
complexes, as the determination of the epitope regions is
based solely on structural-dynamical and energetic properties
of uncomplexed antigens in isolation. The sequences for
the predicted epitopes are reported in Table S3. In Fig. 2,
we have reported the projection of the low energy couplings
on the surfaces of the proteins of the test set.
Evaluation of epitope predictions
To assess the predictivity performance of the MLCE tech-
nique, we used the ROC analysis on all antigens analyzed.
This analysis has been exploited previously in the immuno-
informatics field in epitope prediction efforts (11,12,56) and
is based on the calculation of four main parameters: trueBiophysical Journal 98(9) 1966–1975
FIGURE 2 Projection of the low-energy couplings from
MLCE on their respective locations on the three-dimen-
sional structure of all proteins analyzed. Predicted epitopes
are in red, actual epitopes are in blue, and their intersection
is in purple. Color code: see online version for clarity.
1970 Scarabelli et al.positives (TP), true negatives (TN), false positives (FP), and
false negatives (FN) (57).
The parameters are determined by comparing the predic-
tions with experimental data. For benchmarking, we relied
on published articles on antigen-antibody complexes and
we considered as an epitope the region beginning and ending
with amino acids directly forming interactions with the anti-
body (defined by the crystal data). Our epitope definition also
includes residues directly proximal in sequence with the
previous ones, even though they may not directly contact
the antibody in the complex x-ray structure, as they may
have a relevant role in defining the optimal conformation
required for recognition.
The parameters described above are used to determine the
false-positive rate measure (FPR), defined as
FPR ¼ FP=ðTN þ FPÞ
and the true-positive rate measure (TPR)
TPR ¼ TP=ðTP þ FNÞ:
These are in turn related to the sensitivity, which equals TPR,
or to the specificity, defined as 1-FPR. The dependency of
TPR versus FPR can be plotted in a graph known as the
ROC curve. The area under the ROC curve (also known as
the area under the curve, or AUC) is a good indicator of
the performance of the method, and has been widely used
in the evaluation of other approaches (1,11). ROC curves
are reported in Supporting Material.
We calculated the points in this graph by changing the
cutoff threshold used on the low-energy contact matrix
values to identify the possible epitope residues. To determine
the ROC curve, we considered 19 different cutoff values on
the ordered matrix elements, starting with the set of values
containing the lowest 5% of the filtered contact energy
values and increasing the threshold by 5% per step.
The area under the ROC curve, called AUC, is comprised
between 0 and 1 (with a value of 0.5 for a random classifier)
and it is useful to make comparisons among predictionsBiophysical Journal 98(9) 1966–1975obtained with different methods. We determined the AUC
values to be the sum of the trapezoid areas calculated by
considering the points in the graph. To assess the role of
MD simulations, this analysis was carried out both on the
representative structures obtained from the MD simulations
and on single minimized structures obtained directly from
the PDB. The results are summarized in Table 1.
The MLCE approach provided good performances,
with an average AUC of 0.71. In only one case is the
AUC value < 0.5 (for Histidine-containing phosphocarrier
protein, i.e., HPr, 1poh.pdb). In all other cases, MLCE deter-
mined putative antibody-binding sites with high ranking.
One case of particular interest is lysozyme, where multiple
antibody-binding regions are known (Fig. 3 a). The MLCE
approach proved able to identify these multiple binding sites
(Table 1 and Table S1). The same considerations can be
applied to the cases of the von Willebrand factor A3-domain
protein (vWF-A3, 1ao3.pdb; Fig. 3 b) and human chorionic
gonadotropin (HCG, 1hcn.pdb; Fig. 3 c). Two epitopes have
been mapped on each protein and their location and
sequences were correctly predicted by our approach.
We also evaluated the sensitivity, specificity, and accuracy
of our method, based on the definitions of Ponomarenko and
Bourne (11). Within the chosen threshold, the sensitivity
(the proportion of correctly predicted epitope residues with
respect to the total number of epitope residues) gave an
average value of 0.46, which is slightly better or comparable
to the values reported in the literature (1,11). The results of
specificity (the proportion of correctly predicted nonepitope
residues with respect to the total number of nonepitope
residues) and accuracy (the proportion of correctly predicted
epitope and nonepitope residues with respect to all residues)
provided average values of 0.84 and 0.75, respectively
(Table 1). This confirms the applicability of the approach
to the identification of putative binding-sites on protein
surfaces.
Finally, we evaluated the positive predictive value (PPV)
of MLCE. This value reports on the proportion of correctly
predicted epitope residues with respect to the total number
FIGURE 3 Examples of multiple antibodies binding to the same antigen
(light colored), highlighting the possibility for one protein to possess
multiple epitopes. The PDB code of the antigen is close to the yellow
antigen, and the PDB codes of the complexes are near each respective anti-
body. (a) Lysozyme; (b) the von Willebrand A3 factor; and (c) human cho-
rionic gonadotropin. Color code: see online version for clarity.
MD-Based Epitope Prediction 1971of predicted epitope residues. The results obtained with
MLCE are in line with the performances of several known
predictors of protein-protein interaction sites and protein-
protein docking programs reported in Ponomarenko and
Bourne (11) and in de Vries and Bonvin (1). Based on the
comparison with other algorithms, at least one-half of our
predictions may be useful to direct protein-protein docking
efforts by reliably focusing on the predicted epitope region.
Considering that antigens are notoriously hard to predict, this
can be considered a positive result of the MLCE approach,
given that it relies only on a general physical hypothesis
for protein-protein interactions and on no previous assump-
tions regarding epitope sequences, shapes, etc.
Structural properties of predicted epitopes
The structural properties of predicted binding-sites were
examined to evaluate the ability of the method to retrieve
epitopes from any secondary structure motif, and to discrim-
inate the antibody-binding properties of loops within the
same structure. The case of the OspB C-terminal fragment
from Borrelia burgdorferi (1p4p.pdb) is particularly inter-
esting (Fig. 2). The antibody-binding region is defined by
a discontinuous (conformational) epitope that consists of
residues that belong to three different loops. The protein
also presents several other loops. The MLCE method is
able to discriminate the three loops making up the epitoperegion from the other loops. The epitope-loops are actually
decoupled, in terms of stabilizing interactions, from the
rest of the protein. The remaining loops provide stabilization
energy to the folding core, and thus may not undergo confor-
mational changes, interact with other proteins, or tolerate
mutations without major energetic costs.
Importantly, MLCE could also detect epitopes that are part
of ordered secondary structures. Epitopes with a-helical
structures are predicted for 1auq, 1uw3, and 3lzt. Epitopes
in b-sheet conformations are correctly detected in 1tfh,
1gwp, and 1pko.
In the case of human angiogenin (ANG, 1k59.pdb), MLCE
identifies an additional region of low-energy coupling located
at the opposite face of themolecule from the antibody-binding
site. Indeed, crystal structure determination has shown that
binding of the complementarity determining regions of the
antibody induces a dramatic conformational change precisely
at the region of angiogenin opposite to the epitope (58),
which is used by the protein to bind to cells. Moreover, in
the case of Histidine-containing phosphocarrier protein (HPr,
1poh.pdb), where the calculated AUC value from our calcula-
tion is as low as 0.25, the protein-region of lowest energy
couplings coincides with the substrate-binding site (59,60).
As the epitopes identified with MLCE are minimally
coupled to the rest of the protein, they are also endowed
with higher flexibility, as shown by the root-mean-square
fluctuation graphs reported in Supporting Material. Impor-
tantly, the analysis of flexibility profiles alone is not suffi-
cient to discriminate between epitope and nonepitope
regions. These observations corroborate our hypothesis that
MLCE has the ability to detect sites poised to interact with
other partners.Impact of MD simulations on predictions
The use of MD simulations improved the results of our func-
tional predictions. Indeed, the performance of the method
appears to deteriorate slightly when applied to the structures
of antigens extracted directly from the PDB, yielding an
average AUC of 0.66 (Table 1).
Finally, we also tested the dependency of MLCE perfor-
mance on the simulation length. To this end, each trajectory
was split into 2-ns intervals and the performance was evalu-
ated on increasing timewindows. In general, the performance,
in terms of the resulting AUC value, converges within the first
4–6 ns (data not shown)—showing a possibility that one
might employ shorter simulation times than those proposed
here. In any case, and in view of using the method in a
server-based version, useful predictions can also be obtained
with the use of the simple MM-PBSA approach.DISCUSSION
Reliable prediction of antibody-binding sites for a specific
protein is a condition necessary to the discovery of newBiophysical Journal 98(9) 1966–1975
1972 Scarabelli et al.therapeutic opportunities in immunology. One fundamental
aim of structural vaccinology is the selection of protein
candidates with optimized properties in terms of sequence,
structure, and presentation of the determinants for anti-
body-recognition. In this context, upon being conducted on
new pathogens, high-throughput genomic investigations
(such as those employing RV) may reveal target antigens
that have little sequence similarity to functionally annotated
ones, and which may contain novel folds.
Consequently, it is important to develop computational
methods that can help identify potential epitope regions of
an antigen independently of its sequence and/or shape simi-
larity with other known proteins, and independently of the
knowledge of related structures of antibody complexes.
Starting from these considerations, we set out to develop
a new approach for the identification of possible antibody-
binding sites based uniquely on the structure, dynamics,
and energetics of the protein-antigen in isolation. The corre-
sponding antibody-bound complexes are used for bench-
marking the results.
The approach we propose is based on simple energetic and
conformational concepts. Antigenic proteins must fold to a
well-defined three-dimensional structure to properly carry
out their functions in the pathogen. The stabilization of the
folded state can be achieved through interactions of higher
intensity between specific residues that define the folding
nucleus. Mutations in the folding nucleus have been shown
to impact on protein stability and foldability (43,45–47,61–
63). In contrast, epitopes are typically mutation-prone sites
(24,32): a protein from a pathogen should, in fact, be able
to tolerate mutations that could help it evade the immune
defense system of a host.
The energy decomposition method that we introduced
and tested proved able to single out the residues of the
folding nucleus and flag their contribution to stabilization
energy (43,47). The ability to identify the folding nucleus
complementarily determines the possibility to identify posi-
tions that are more tolerant to mutations. Typically, they
coincide with the residues characterized by low energetic
couplings with the remainder of the protein. Moreover,
low-intensity couplings between proximal residues define
sites whose interaction-networks are not energetically opti-
mized and which are generally located on the surface.
From the dynamic point of view, these substructures may
easily undergo conformational transitions and fluctuations
favoring the docking of potential binding partners through
a conformational selection mechanism (64). Binding of a
specific antibody partner would thus select specific geome-
tries of the antigen, shifting the equilibrium toward thermo-
dynamically stable complexes.
Based on these premises, the positioning of these sites can
be identified in a compact way by multiplying the simplified
energy-coupling matrix by the residue-contact matrix. This
procedure allows us to filter the information contained in
the simplified energy matrix in terms of residues that areBiophysical Journal 98(9) 1966–1975close in space, highlighting pairs within the contact cutoff
that are also energy-coupled through nonbonded interactions
in the three-dimensional structure. By concentrating on the
lowest energy-coupled pairs in contact according to the
contact matrix definition, it is possible to identify surface
patches that can be recognized by a putative binding partner.
It is important to underline that we aim at identifying,
specifically, locally organized residues with nonoptimized
interaction energy-networks that are independent of possible
dynamic signatures. Interestingly, analysis of normal modes
or cross-correlation coefficients of residue pairs could not
identify any specific, nonrandom fluctuations involving spa-
tially localized regions with the lowest energetic-couplings.
Epitopes are characterized by (anti)correlated as well as
random motions with the rest of the protein or with other
parts of the conformational epitope. This aspect can be inter-
preted in the light of the weak energy-couplings among
epitope residues, which result in higher flexibility and in
the absence of major conformational constraints to the rest
of the protein.
The surface patches identified through our procedure
define the three-dimensional, structured landscapes associ-
ated with discontinuous epitopes that are recognized by anti-
bodies.
It is worth noting, once more, that the whole procedure for
epitope identification is based on the study of the antigen in
isolation, and the structures of antigen-antibody complexes
are used only as a posteriori validations of the analysis.
The predictivity, specificity, and accuracy of the method
are in line with what has been reported recently in the
literature (1,11).
Interestingly, MLCE proves able to identify multiple
epitope sites encompassing different antigen regions
(Fig. 3). A certain protein surface may in fact contain several
possible antibody-binding sites that may not be represented
in the sets of structures currently available.
Spatially localized sites with low energetic coupling to
the rest of the protein may determine the dynamics required
for specific function and/or recognition of partners other
than just antibodies (65). In the case of angiogenin (ANG,
1k59.pdb), in addition to correctly predicting the epitope,
our method detects the cell-binding region of angiogenin at
the opposite part of the molecule from the combining site
(58). In the case of Histidine-containing phosphocarrier
protein (HPr, 1poh.pdb), the regions of low-coupling energy
include the phosphate-binding site, located in the N-terminal
region.
Nonoptimized interaction networks can be exploited
by the protein to modulate structural plasticity and local
flexibility and provide conformational and functional adapt-
ability to possible binding partners. As is also suggested by
Ferreiro et al. (53), localizing alternate conformational states
or sequence mutations on specific substructures, while mini-
mizing the influence on the three-dimensional stability
required for function, could provide a mechanism of specific
MD-Based Epitope Prediction 1973control of motions by concentrating only on a subregion of
the protein.
The MD-based method we propose is clearly not as effi-
cient, in terms of computational expenses, as are dedicated
bioinformatics tools and servers that build on different ideas
(12,56,66,67). In most cases, the use of MD structures (either
the most representative conformation from cluster analysis or
averaging over the trajectories) gives only slight improve-
ments over direct minimization of the PDB structure of the
antigen. MD-related performance improvements in our
data set are noticed mainly for cases in which an epitope is
shared between a secondary structure element and a loop.
The release of strain determined by the initial crystal packing
and consequent conformational relaxation determined by
MD favor the geometric and energetic organization opti-
mized for the recognition of the binding partner. In this
framework, the role of MD can be most relevant in cases
where major structural rearrangements are involved, e.g.,
in domain motions, large conformational changes, and local
folding-unfolding. These cases were not present in our initial
dataset, but correct epitope predictions have already been
obtained for multidomain amino-acid transporting proteins
from the pathogen Chlamydia (M. Soriani, P. Petit, R. Gri-
fantini, R. Petracca, G. Gancitano, E. Frigimelica, C. Garcia,
S. Spinelli, G. Scarabelli, S. Fiorucci, R. Affentranger,
M. Ferrer-Navarro, M. Zacharias, G. Colombo, L. Vuillard,
X. Daura, and G. Grandi, unpublished).
Given all these caveats, it is, however, important to under-
line that the aim of the study was to introduce a conceptually
different approach. We notice that dramatic improvements in
algorithms and hardware solutions (68–70) might make it
possible to obtain large-scale MD-based predictions more
quickly and on longer timescales.
Despite its limitations, we think that the MLCE method
may be a valid tool to direct epitope-mapping experiments
and possibly identify binding patches to restrict the search
of binding poses in protein-protein docking algorithms.
With regard to epitope mapping, our approach is already
being applied to targets of industrial interest (M. Soriani,
P. Petit, R. Grifantini, R. Petracca, G. Gancitano, E. Frigimel-
ica, C. Garcia, S. Spinelli, G. Scarabelli, S. Fiorucci, R. Affen-
tranger, M. Ferrer-Navarro, M. Zacharias, G. Colombo,
L. Vuillard, X. Daura, and G. Grandi, unpublished). Further
improvement of the predictions may be obtained by inte-
grating MLCE with other predictors that are based on bioin-
formatics analysis.
From the point of view of possible applications, ourmethod
may be relevant for structure-based vaccine design. One
could, in fact, focus antigen mutagenesis on those regions
that are not part of the folding core and, by so doing, preserve
the fold and leave the three-dimensional structure of the
protein and epitope presentation unchanged. Random or
site-directed mutagenesis could thus be concentrated upon
the putative epitope sites, eventually selecting new sequences
with maximum affinity for neutralizing antibodies. An alter-native strategy would imply the stabilization of the structure
of the antigen by engineering Cys cross-linking mutations,
or by further optimization of the folding core, to obtain a domi-
nant conformation that would stably present the antibody
recognition determinants rather than transiently populate
binding conformations.
Finally, by knowing which parts of the antigens can be
modified and which should be left unchanged to retain effi-
cient neutralizing antibody recognition, protein antigens
could be modified and selected to optimize production and
storage, with an impact on costs and distributions of potential
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